Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Study of Anginera In Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Phase 1
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2009-03-30
- Lead Sponsor
- Theregen, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT00364390
- Locations
- 🇺🇸
Yale University School of Medicine,, New Haven, Connecticut, United States
🇺🇸University of Maryland School of Medicine, Baltimore, Maryland, United States
Study of Anginera in Adults With a Left Ventricular Assist Device (LVAD) as Bridge to Transplant
Phase 1
- Conditions
- Heart Failure
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2009-03-30
- Lead Sponsor
- Theregen, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT00364598
- Locations
- 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
🇺🇸University of Maryland School of Medicine, Baltimore, Maryland, United States
🇺🇸University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States
News
No news found